All in all, the correlation between IFI27 expression and FOXP3 was supported by clinical samples and TCGA BCa patient data, suggesting that the IFI27/PD-1/FOXP3 axis was involved in the modulation of anti-tumor immune processes in BCa. This evidence concerns the gene FOXP3 and neoplasm.